INVOKAMET XR is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Janssen Pharmaceuticals, Inc.. The primary component is Canagliflozin; Metformin Hydrochloride.
| Product ID | 50458-941_2276e4f3-2afe-48ac-b293-fd4befeff063 |
| NDC | 50458-941 |
| Product Type | Human Prescription Drug |
| Proprietary Name | INVOKAMET XR |
| Generic Name | Canagliflozin And Metformin Hydrochloride |
| Dosage Form | Tablet, Film Coated, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-09-20 |
| Marketing Category | NDA / NDA |
| Application Number | NDA205879 |
| Labeler Name | Janssen Pharmaceuticals, Inc. |
| Substance Name | CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
| Active Ingredient Strength | 50 mg/1; mg/1 |
| Pharm Classes | Sodium-Glucose Cotransporter 2 Inhibitor [EPC],Sodium-Glucose Transporter 2 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Biguanide [EPC],Biguanides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2016-09-20 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA205879 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-09-20 |
| Marketing Category | NDA |
| Application Number | NDA205879 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2016-09-20 |
| Marketing End Date | 2020-02-07 |
| Ingredient | Strength |
|---|---|
| CANAGLIFLOZIN | 50 mg/1 |
| SPL SET ID: | 6868666b-c25e-40d1-9d1f-306bbe9390c1 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 50458-940 | INVOKAMET XR | canagliflozin and metformin hydrochloride |
| 50458-941 | INVOKAMET XR | canagliflozin and metformin hydrochloride |
| 50458-942 | INVOKAMET XR | canagliflozin and metformin hydrochloride |
| 50458-943 | INVOKAMET XR | canagliflozin and metformin hydrochloride |
| 50458-540 | INVOKAMET | canagliflozin and metformin hydrochloride |
| 50458-541 | INVOKAMET | canagliflozin and metformin hydrochloride |
| 50458-542 | INVOKAMET | canagliflozin and metformin hydrochloride |
| 50458-543 | INVOKAMET | canagliflozin and metformin hydrochloride |
| 63629-8260 | INVOKAMET | canagliflozin and metformin hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() INVOKAMET XR 86277042 5134045 Live/Registered |
JOHNSON & JOHNSON 2014-05-09 |